Camardo Daniel A.
SEC CIK 1820365 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| CUE | Cue Biopharma, Inc. | Dir | 21.8K | — | — | 1 | 2026-07-09 | 2026-07-09 |
Most active insiders at CUE, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Lin Shao-Lee | CEO, Dir | — | $1.61M |
| 2 | Ray Sumita | Chief Legal Compliance Off, Corp. Sec | — | $265.6K |
| 3 | Meluzio Michael Vincent | VP, Prin. Accounting Off | — | $169.3K |
| 4 | Sarraf Pasha | Dir | $99.7K | — |
| 5 | Meehan Viola Mong | Dir | — | — |
| 6 | Borie Dominique Christian | Chief Medical Off, Head of Research, Development | — | — |
| 7 | Garzone Pamela | Dir | — | — |
| 8 | Camardo Daniel A. | Dir | — | — |
| 9 | Ahlers James M | CFO | — | — |
Transactions 1
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-10 19:37 | 2026-07-09 | CUE | Cue Biopharma, Inc. | Camardo Daniel A. | Dir | A - Grant | $0.00 | +21.8K | 21.8K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations